NAVLIN Price & Access Data
Good Decisions Start With The Most Accurate Data
NAVLIN Price & Access Data is the industry’s most comprehensive, highly accurate database of global price and market access intelligence, providing the right answers to the right questions to inform your strategy at launch and beyond.
- 100+
- countries
- <24 Hours
- updates made from time of publication
- +40
- bodies of HTA decisions
- 99.8%
- data accuracy
- 5.5M
- price points
NAVLIN Price & Access Data
NAVLIN Price & Access Data provides global teams with the data they need in a single consolidated environment.
-
Price Intelligence - Monitor competitors’ responses to your price changes, get daily updates on global prices and more via our easy-to-use web portal and mobile app.
-
HTA Data - Easily compare decisions across products and their comparators at the indication level with the most comprehensive HTA coverage.
-
Tender Data - Improve strategic decision-making process with global analytics and insights to local dynamics in real time.
-
Cost of Treatment Data - Compare costs across therapies and indications using our cost-of-treatment calculator.
-
Reimbursement Data - Track reimbursement data by indication for key global markets.
-
News and Country Reports - Get daily policy and reimbursement updates for products around the globe.
The NAVLIN Difference
- Accurate
NAVLIN Price & Access Data is updated in real time, providing users with the industry’s most accurate pricing and market access data. Our database manages every product in more than 100 countries and provinces, including complete historical coverage in most countries.
- Easy To Use
The combination of comprehensive pricing and market access data, one-click insights and expert support enables teams to focus on strategy and improved decision-making.
- Expert Support
Our team of analysts offers 24×7 support and assists in the development of custom reports to meet your most pressing needs.
- Comprehesive
NAVLIN Price & Access Data provides global pricing, analytics, HTA, regulatory, clinical, and economic data along with news and insights in a single platform.